financetom
Business
financetom
/
Business
/
Beneficient Adds $35 Million in Permanent Equity to Balance Sheet in Effort to Regain Nasdaq Compliance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beneficient Adds $35 Million in Permanent Equity to Balance Sheet in Effort to Regain Nasdaq Compliance
Nov 22, 2024 5:23 AM

07:53 AM EST, 11/22/2024 (MT Newswires) -- Beneficient (BENF) said Friday it has added $35 million in permanent equity on its balance sheet after its subsidiary redesignated around $35 million of its preferred equity as non-redeemable.

Beneficient said it believes it now meets Nasdaq's minimum stockholders' equity requirement of at least $2.5 million, however, it is subject to Nasdaq's final determination.

The company shares were up over 13% in recent premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tapestry Stock Falls Despite Q1 Earnings Beat, Raised FY26 Guidance
Tapestry Stock Falls Despite Q1 Earnings Beat, Raised FY26 Guidance
Nov 6, 2025
Tapestry, Inc. ( TPR ) shares are trading lower on Thursday. The company reported first-quarter financial results before the market opened. TPR is encountering selling pressure. See if it is worth your attention here. What To Know: Tapestry reported adjusted earnings per share of $1.38, beating the consensus estimate of $1.26. The Coach and Kate Spade parent company reported sales of...
Clear Channel Outdoor Shares Fluctuate After Q3 Net Loss Widens
Clear Channel Outdoor Shares Fluctuate After Q3 Net Loss Widens
Nov 6, 2025
10:31 AM EST, 11/06/2025 (MT Newswires) -- Clear Channel Outdoor ( CCO ) shares fluctuated between gains and losses in recent Thursday trading after the company reported a Q3 net loss that widened from a year earlier. The net loss of $0.12 per diluted share compared with the loss of $0.07 a year earlier. Four analysts polled by FactSet expected...
Medicenna's MDNA-11 to Be Tested With Immunotherapies in Italian Melanoma Trial
Medicenna's MDNA-11 to Be Tested With Immunotherapies in Italian Melanoma Trial
Nov 6, 2025
10:36 AM EST, 11/06/2025 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) said Thursday its lead candidate MDNA-11 is being tested with two major immunotherapies in an Italian clinical trial. The trial, Neo-Cyt, involves patients with high-risk, surgically resectable Stage III cutaneous melanoma and is sponsored by the non-profit Melanoma Foundation at the National Cancer Institute's G. Pascale Foundation in...
Form 8.3
Form 8.3
Nov 6, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved